Prevalence of MS Increased Substantially From 1990 to 2016
June 21, 2019Substantially increased since 1990, according to study results published in Lancet Neurology.read more
All News
New Genetic Links With Vitamin D Discovered In MS
June 4, 2019Low vitamin D has long been a risk factor for developing MS, but how does that tie in with MS risk genes?read more
Mabs – The Secret Agents Fighting MS
June 4, 2019What do the MS treatments ocrelizumab, alemetuzumab and natalizumab (Ocrevus, Lemtrada, and Tysabri) have in common?read more
Who’s Who at NZMSRT: Neil Woodham’s
May 5, 2019We recently took the opportunity to find out a bit more about one of our original Trustees and his thoughts on the future of MS Research in New Zealand.read more
The National MS Society (USA) Commits Over $24 Million to 64 New Research Projects
May 2, 2019To stop MS, restore function and end MS Foreverread more
The Next Atlas Of MS Is Underway
May 1, 2019MSIF’s Atlas of MS with new data on the number of people living with MS across the worldread more
Global Webcast On Solving Progressive MS
May 1, 2019Progress achieved and hope for the futureread more
Temperature Sensitivity in Multiple Sclerosis Online Survey
March 27, 2019For those with MS that have experienced symptoms worsening due to heat and coldread more
Tisch Ms Research Center Of New York Awarded $1 Million National MS Society Grant For Phase II Stem Cell Research
March 20, 2019Momentum continues in landmark study targeting repair and regenerationread more
ECTRIMS 2018
March 20, 2019Research Review of the 34th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), held in Berlin.read more
Landmark Study Estimates Nearly 1 Million in the U.S. Have Multiple Sclerosis
March 20, 2019A new study funded by the National MS Society has confirmed that nearly one million people are living with MS in the United States, more than twice the original estimate…read more
Family Planning in MS: Dispelling Myths and Encouraging Conversations
February 13, 2019A survey of patients with MS showed gaps in their understanding of the relationship between MS and pregnancy and the implications for treatment of relapses.read more
Ocrelizumab Reduces Upper Extremity Disability Progression Risk in PPMS
February 13, 2019Study results published show a noticeably reduced risk for progression of upper extremity (UE) disability compared with placebo in patients with primary progressive multiple sclerosis (PPMS)read more
Prevalence of Pediatric Multiple Sclerosis Exceptionally High in Ontario, Canada Compared With Global Numbers
February 13, 2019According to the results of a population-based studyread more
Interferon-Beta, Glatiramer Acetate Equally Effective for Relapsing-Remitting MS
February 13, 2019Interferon-Beta, Glatiramer Acetate Equally Effective for Relapsing-Remitting MSread more
International consensus on quality standards for brain health-focused care in multiple sclerosis
January 24, 2019Time matters in multiple sclerosis (MS). Irreversible neural damage and cell loss occur from disease onsetread more
Development and validation of a speech pathology-specific questionnaire for persons with multiple sclerosis (SMS)
January 23, 2019Research findingsread more
2018 GLOBAL BRAIN SUMMIT
January 14, 2019Recording, presentation and abstracts from summitread more